Avidity Biosciences Inc (RNA)
52.16
-0.39
(-0.74%)
USD |
NASDAQ |
Nov 14, 10:39
Avidity Biosciences Price: 52.16 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 47.32 | 56.00 | 46.82 | 52.55 | 3.212M |
| Nov 12, 2024 | 46.06 | 47.99 | 45.65 | 46.73 | 1.082M |
| Nov 11, 2024 | 47.09 | 48.32 | 46.44 | 47.12 | 979322.0 |
| Nov 08, 2024 | 46.76 | 47.30 | 44.85 | 46.72 | 1.076M |
| Nov 07, 2024 | 47.38 | 48.72 | 46.47 | 47.51 | 845477.0 |
| Nov 06, 2024 | 46.85 | 47.30 | 44.30 | 47.24 | 1.272M |
| Nov 05, 2024 | 44.82 | 45.43 | 43.39 | 45.09 | 764852.0 |
| Nov 04, 2024 | 41.40 | 45.58 | 41.12 | 44.82 | 1.451M |
| Nov 01, 2024 | 42.74 | 43.48 | 41.36 | 41.87 | 1.122M |
| Oct 31, 2024 | 43.10 | 43.17 | 42.18 | 42.26 | 854008.0 |
| Oct 30, 2024 | 44.05 | 44.61 | 43.22 | 43.22 | 549653.0 |
| Oct 29, 2024 | 45.24 | 45.67 | 44.03 | 44.57 | 485921.0 |
| Oct 28, 2024 | 46.01 | 46.64 | 45.40 | 45.72 | 629603.0 |
| Oct 25, 2024 | 45.50 | 46.30 | 45.08 | 45.11 | 575049.0 |
| Oct 24, 2024 | 45.47 | 46.29 | 44.75 | 45.15 | 417530.0 |
| Oct 23, 2024 | 47.13 | 47.29 | 45.24 | 45.40 | 793584.0 |
| Oct 22, 2024 | 46.15 | 48.23 | 46.15 | 47.38 | 489205.0 |
| Oct 21, 2024 | 49.96 | 50.40 | 45.83 | 46.71 | 1.168M |
| Oct 18, 2024 | 48.50 | 50.78 | 47.80 | 50.45 | 1.212M |
| Oct 17, 2024 | 48.74 | 49.12 | 48.02 | 48.52 | 634881.0 |
| Oct 16, 2024 | 47.16 | 49.60 | 46.52 | 48.94 | 1.115M |
| Oct 15, 2024 | 46.65 | 47.22 | 45.20 | 46.70 | 501885.0 |
| Oct 14, 2024 | 46.09 | 47.21 | 45.58 | 46.71 | 493208.0 |
| Oct 11, 2024 | 44.11 | 46.62 | 43.76 | 46.60 | 744729.0 |
| Oct 10, 2024 | 44.59 | 45.98 | 43.13 | 44.22 | 763984.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.87
Minimum
Oct 27 2023
52.55
Maximum
Nov 13 2024
21.79
Average
21.87
Median
Mar 25 2021
Price Benchmarks
| Sarepta Therapeutics Inc | 110.20 |
| Natera Inc | 159.10 |
| Entrada Therapeutics Inc | 19.67 |
| Alnylam Pharmaceuticals Inc | 261.39 |
| Catalyst Pharmaceuticals Inc | 21.76 |
Price Related Metrics
| PS Ratio | 423.62 |
| Price to Book Value | 5.003 |
| Earnings Yield | -5.66% |
| Market Cap | 6.109B |